Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

726

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Acne Vulgaris
Interventions
DRUG

S6G5T-3

once a day topical cream

DRUG

S6G5T-1

once a day topical cream

DRUG

S6G5T-5

once a day topical cream

DRUG

S6G5T-6

once a day topical cream

DRUG

S6G5T-7

once a day topical cream

DRUG

S6G5T-8

once a day topical cream

Trial Locations (34)

3801

ActivMed Practices and Research, Inc., Portsmouth

10018

New York Clinical Trials, Manhattan

11790

Derm Research Center of New York, Inc, Stony Brook

19103

Paddington Testing Co, Inc, Philadelphia

27262

Dermatology Consulting Services, High Point

27612

Wake Research Associates, LLC, Raleigh

29607

Palmetto Clinical Trial Services, LLC @ Greenville Dermatology, Greenville

33126

LCC Medical Research Institute, LLC, Miami

33144

Oceane7 Clinical Research, Miami

33157

IMIC Inc., Palmetto Bay

33175

RM Medical Research, LLC, Miami

33458

Health Awareness, Inc., Jupiter

33511

MOORE Clinical Research, Inc, Brandon

33607

Clinical Research Trials of Florida, Inc., Tampa

33634

Meridien Research, Tampa

40202

Dermatology Specialists Research, Louisville

40217

DermResearch, PLLC, Louisville

64506

MediSearch clinical Trials, Saint Joseph

67010

Heartland Research Associates, LLC, Augusta

68114

Quality Clinical Research Inc., Omaha

70115

DelRicht Research, New Orleans

77055

West Houston Clinical Research Services LLC, Houston

77802

Discover Research, Inc., Bryan

78218

Texas Dermatology and Laser Specialists, San Antonio

78660

Austin Institute for Clinical Research, Inc., Pflugerville

80220

Horizons Clinical Research Center, LLC, Denver

89109

eStudySite, Las Vegas

90045

Dermatology Research Associates, Los Angeles

90703

Core Healthcare Group, Cerritos

91436

T. Joseph Raoof MD, Inc./Encino Research Center, Encino

91786

Empire Clinical Research, Upland

91911

eStudySite, Chula Vista

92056

eStudySite, Oceanside

92801

Orange County Research Institute, Anaheim

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Accelovance

INDUSTRY

lead

Sol-Gel Technologies, Ltd.

INDUSTRY

NCT02661958 - Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris | Biotech Hunter | Biotech Hunter